jeffreybrowen posted: " By BY PAM BELLUCK, SHEILA KAPLAN AND REBECCA ROBBINS Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen's Aduhelm, or aducanumab. Published: July 19, 2021 at 10:12PM "
|
Subscribe to:
Post Comments (Atom)
-
yvonnembee posted: " I have had a great week with the book reading, there have been some fabulous ones. The weather here ha...
-
trentbartlett posted: "Rumours around this snack's return have been floating around the internet for a little while now...

No comments:
Post a Comment